MedicaidAdministrativeMedium impact
Medicaid Alert - MA-1996-04
New Jersey Medicaid·NJ · Pulmonology, Internal Medicine, Family Medicine·Coding
We identified it
Jun 20, 2026
Summary
New Jersey Medicaid has issued clarification on billing procedures for Prolastin injection, a treatment typically used for alpha-1 antitrypsin deficiency. This fresh policy update may affect how providers submit claims and document medical necessity for this specialized medication.
Action Required
Immediately: Review the full policy document at https://www.njmmis.com/documentDownload.aspx?document=ma1996-04.pdf to understand specific billing procedure changes for Prolastin injections. Billing team must update procedures according to the clarified requirements to ensure proper claim submission and avoid denials.